Stock Evaluator: SANUWAVE Health, Inc. (SNWV)

SANUWAVE Health, Inc. SNWV

$4.38 -0.07 -1.57%
September 4, 2026 4:00:00 PM EST November 10, 2021 Volume: 46,244
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Commentary & Analysis


Financial Summary

Share Statistics SNWV Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $37.7 $423.0 13%
Shares Out (Mil) 8.6 41.5 19%
Institutional Ownership 83.6% 83.6% 51%
Float (Mil) 6.2 35.5 14%
Beta 1.50 0.88 82%
Avg Daily Volume (000s) 40 346 27%
Price Change
(52-week)
(88.7%) 65.4% 4%
Growth SNWV Industry
Median
Percentile
(All Stocks)
Sales (5yr) 60.8% 11.8% 97%
Net Income (5yr) 19.0% (5.8%) 71%
EPS (5yr) 15.0% 10.4% 56
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (21.5%) (15.5%) 30%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials SNWV Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $44 $119 19%
Net Income (TTM) (Mil) $15 ($9) 47%
EPS (TTM) $1.778 ($0.400) 69%
Operating Cash Flow (TTM) (Mil) $5 ($3) 36%
Net Cash Flow (TTM) (Mil) $1 $1 46%
Long-Term Debt (Q1) (Mil) $15 $23 31%
Enterprise Value (Q1) (Mil) $59 $376 17%
Valuation SNWV Industry
Median
Percentile
(All Stocks)
P/B 13.69 2.85 93%
P/E 5.6 27.6 5%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 0.4 1.6 17%
Ratios SNWV Industry
Median
Percentile
(All Stocks)
Gross Margin 76.3% 58.5% 86%
Net Margin 34.7% (6.9%) 92%
ROA 43.8% (13.3%) 99%
ROE (254.6%) (13.3%) 3%
Liabilities to Assets 92.4% 46.0% 90%
F-Score 4 4 33%

SANUWAVE Health, Inc. did not pass any screens on 9/4/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors